BRPI0511186A - composto, pró-droga do composto, composição farmacêutica, uso do composto, e, processo para preparar o composto - Google Patents

composto, pró-droga do composto, composição farmacêutica, uso do composto, e, processo para preparar o composto

Info

Publication number
BRPI0511186A
BRPI0511186A BRPI0511186-2A BRPI0511186A BRPI0511186A BR PI0511186 A BRPI0511186 A BR PI0511186A BR PI0511186 A BRPI0511186 A BR PI0511186A BR PI0511186 A BRPI0511186 A BR PI0511186A
Authority
BR
Brazil
Prior art keywords
compound
optionally substituted
bond
prodrug
pharmaceutical composition
Prior art date
Application number
BRPI0511186-2A
Other languages
English (en)
Inventor
Keiji Kubo
Yasuhiro Imaeda
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of BRPI0511186A publication Critical patent/BRPI0511186A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)

Abstract

COMPOSTO, PRó-DROGA DO COMPOSTO, COMPOSIçãO FARMACêUTICA, USO DO COMPOSTO, E , PROCESSO PARA PREPARAR O COMPOSTO A presente invenção fornece um derivado de amida cíclica útil como um medicamento para tratar fórmula (I): em que R¬ 1¬ representa um grupo hidrocarboneto cíclico opcionalmente substituído ou um grupo heterocíclico opcionalmente substituído. W representa uma ligação ou um grupo hidrocarboneto de cadeia divalente opcionalmente substituído, a representa 0,1 ou 2, X¬ 1¬ representa um alquileno inferior opcionalmente substituído ou um alquenileno inferior opcionalmente substituído, Y¬ 1¬ representa -C(O)-, -S(O)- ou -S(O)~ 2~-, A representa um anel piperazina que pode ser ainda substituído ou um anel piperidina que pode ser ainda substituído, X¬ 2¬ representa uma ligação ou um alquileno inferior opcionalmente substituído, Y¬ 2¬ representa -C(O)-, -S(O)-, -S(O~ 2~- ou -C(=NR¬ 7¬)-, X¬ 3¬ representa um alquileno C~ 1~-~ 4~ opcionalmente substituído ou um alquenileno C~ 2~-~ 4~ opcionalmente substituído, Z¬ 3¬ representa - N(R¬ 4¬)-, -O- ou uma ligação, Z¬ 1¬ representa -C(R¬ 2¬) (R¬ 2¬)-, -N(R¬ 2¬)-, etc., e Z¬ 2¬ representa -C(R¬ 3¬)(R¬ 3¬)-, -N(R¬ 3¬)-, etc., ou um sal destes.
BRPI0511186-2A 2004-05-21 2005-05-20 composto, pró-droga do composto, composição farmacêutica, uso do composto, e, processo para preparar o composto BRPI0511186A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004152000 2004-05-21
PCT/JP2005/009711 WO2005113504A1 (en) 2004-05-21 2005-05-20 Cyclic amide derivatives, and their production and use as antithrombotic agents

Publications (1)

Publication Number Publication Date
BRPI0511186A true BRPI0511186A (pt) 2007-12-04

Family

ID=34968275

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0511186-2A BRPI0511186A (pt) 2004-05-21 2005-05-20 composto, pró-droga do composto, composição farmacêutica, uso do composto, e, processo para preparar o composto

Country Status (26)

Country Link
US (4) US7745623B2 (pt)
EP (2) EP2208726B1 (pt)
JP (2) JP4129047B2 (pt)
KR (1) KR101248637B1 (pt)
CN (2) CN1989104B (pt)
AT (1) ATE513813T1 (pt)
AU (1) AU2005245298B2 (pt)
BR (1) BRPI0511186A (pt)
CA (1) CA2567506C (pt)
CY (1) CY1111850T1 (pt)
DK (1) DK1748985T3 (pt)
ES (1) ES2368155T3 (pt)
HK (1) HK1100666A1 (pt)
HR (1) HRP20110640T1 (pt)
IL (1) IL178896A (pt)
MX (1) MXPA06013243A (pt)
MY (1) MY154461A (pt)
NO (1) NO20065929L (pt)
NZ (1) NZ550985A (pt)
PL (1) PL1748985T3 (pt)
PT (1) PT1748985E (pt)
RS (1) RS51925B (pt)
RU (1) RU2361861C2 (pt)
SI (1) SI1748985T1 (pt)
TW (1) TWI396686B (pt)
WO (1) WO2005113504A1 (pt)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2416384A1 (en) * 2000-07-17 2003-01-16 Takeda Chemical Industries, Ltd. Sulfone derivatives, their production and use
CA2507026A1 (en) * 2002-11-22 2004-06-10 Takeda Pharmaceutical Company Limited Imidazole derivatives, their production and use
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
WO2007114861A2 (en) * 2005-11-28 2007-10-11 Zymogenetics, Inc. Il-21 receptor antagonists
WO2008066102A1 (fr) * 2006-11-30 2008-06-05 Takeda Pharmaceutical Company Limited Préparation à libération prolongée
TW201014850A (en) 2008-09-25 2010-04-16 Takeda Pharmaceutical Solid pharmaceutical composition
EP2351743A4 (en) 2008-10-27 2012-05-09 Takeda Pharmaceutical BICYCLIC CONNECTION
EP2371826A4 (en) 2008-12-29 2012-06-27 Takeda Pharmaceutical NEW CONNECTION WITH CONDENSED RINGS AND ITS USE
UY32395A (es) 2009-01-27 2010-08-31 Takeda Pharmaceutical Compuesto con anillo fusionado y su uso
NZ596395A (en) 2009-04-30 2013-06-28 Takeda Pharmaceutical Stable solid benzimidazole derivative preparation having optimized dissolution property
US20120172351A1 (en) 2009-06-09 2012-07-05 Nobuyuki Negoro Novel fused cyclic compound and use thereof
JP5732394B2 (ja) 2009-07-28 2015-06-10 武田薬品工業株式会社 錠剤
US8221489B2 (en) * 2009-08-20 2012-07-17 Stentys Device and method for treating a body lumen
BR112012027648A2 (pt) 2010-04-27 2019-09-24 Takeda Pharmaceuticals Co composto medicamento, método para profilaxia ou tratamento de doença, e, uso de composto
BR112012032055B8 (pt) 2010-06-16 2019-11-12 Takeda Pharmaceuticals Co cristal de cloridrato de 1-(4-metoxibutil)-n-(2-metilpropil)-n-[(3s,5r)-5-(morfolin-4-ilcarbonil)piperidin-3-il]-1h-benzimidazol-2-carboxamida, medicamento, e, uso do cristal
CA2806258A1 (en) 2010-07-23 2012-01-26 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and application thereof
US20130184272A1 (en) 2010-09-17 2013-07-18 Takeda Pharmaceutical Company Limited Diabetes therapeutic agent
US8729102B2 (en) 2010-11-30 2014-05-20 Takeda Pharmaceutical Company Limited Bicyclic compound
MX2013009526A (es) 2011-02-17 2013-10-01 Takeda Pharmaceutical Metodo de produccion de derivado de dihidrobenzofurano opticamente activo.
EP2772485A4 (en) 2011-10-24 2015-06-10 Takeda Pharmaceutical BICYCLIC CONNECTION
JP6129850B2 (ja) 2012-01-12 2017-05-17 武田薬品工業株式会社 Ｍｃｈ受容体拮抗剤としてのベンゾイミダゾール誘導体
US9181186B2 (en) 2012-02-13 2015-11-10 Takeda Pharmaceutical Company Limited Aromatic ring compound
JP6095580B2 (ja) 2012-02-13 2017-03-15 武田薬品工業株式会社 芳香環化合物
WO2013122260A1 (en) 2012-02-15 2013-08-22 Takeda Pharmaceutical Company Limited Tablet
US9238639B2 (en) 2012-02-24 2016-01-19 Takeda Pharmaceutical Company Limited Aromatic ring compound
JPWO2013147026A1 (ja) 2012-03-29 2015-12-14 武田薬品工業株式会社 芳香環化合物
US9440987B2 (en) 2012-05-10 2016-09-13 Takeda Pharmaceutical Company Limited Aromatic ring compound
US9505772B2 (en) 2012-05-10 2016-11-29 Takeda Pharmaceutical Company Limited Aromatic ring compound
UY34847A (es) 2012-06-05 2014-01-31 Takeda Pharmaceutical Preparacion sólida
JP2015127299A (ja) 2012-07-19 2015-07-09 武田薬品工業株式会社 固形製剤
JPWO2014030743A1 (ja) 2012-08-24 2016-08-08 武田薬品工業株式会社 複素環化合物
CN103936763B (zh) * 2013-01-18 2017-10-31 中国科学院上海药物研究所 噁唑烷酮类化合物及其制备方法和用途
EP2970331B1 (en) 2013-03-14 2017-05-17 Takeda Pharmaceutical Company Limited Spiro azetidine isoxazole derivatives and their use as sstr5 antagonists
WO2014165816A1 (en) 2013-04-05 2014-10-09 North Carolina Central University Compounds useful for the treatment of metabolic disorders and synthesis of the same
EP3019487A1 (en) 2013-07-09 2016-05-18 Takeda Pharmaceutical Company Limited Heterocyclic compound
JP6397410B2 (ja) 2013-08-09 2018-09-26 武田薬品工業株式会社 芳香環化合物
JO3442B1 (ar) 2013-10-07 2019-10-20 Takeda Pharmaceuticals Co مضادات ذات نوع فرعي من مستقبل سوماتوستاتين 5 (sstr5)
US9428470B2 (en) 2014-02-13 2016-08-30 Takeda Pharmaceutical Company Limited Heterocyclic compound
US9346776B2 (en) 2014-02-13 2016-05-24 Takeda Pharmaceutical Company Limited Fused heterocyclic compound
WO2016045587A1 (zh) * 2014-09-26 2016-03-31 常州寅盛药业有限公司 作为ns4b抑制剂的苯并呋喃类似物
ES2829675T3 (es) 2014-12-23 2021-06-01 Crossing S R L Reactivos que comprenden 2-halo-4,6-dialcoxi-1,3,5-triazinas en presencia de aminas y su uso en un método de estabilización
AR111199A1 (es) 2017-03-31 2019-06-12 Takeda Pharmaceuticals Co Compuesto aromático agonista de gpr40
JOP20180028A1 (ar) 2017-03-31 2019-01-30 Takeda Pharmaceuticals Co مركب ببتيد
WO2018181847A1 (ja) 2017-03-31 2018-10-04 武田薬品工業株式会社 芳香環化合物
US11207312B2 (en) 2017-07-17 2021-12-28 Merck Sharp & Dohme Corp. Metallo-beta-lactamase inhibitors and methods of use thereof
KR20210008834A (ko) 2018-03-23 2021-01-25 카모트 테라퓨틱스, 인크. G-단백질 결합 수용체의 조절제
AR116019A1 (es) 2018-08-27 2021-03-25 Scohia Pharma Inc Derivados de guanidinobenzoilo como inhibidores de enteropeptidasa
JP2022503793A (ja) 2018-09-24 2022-01-12 武田薬品工業株式会社 Ｇｉｐ受容体アゴニストペプチド化合物及びその使用
JP2022500483A (ja) 2018-09-24 2022-01-04 武田薬品工業株式会社 Ｇｉｐ受容体アゴニストペプチド化合物及びその使用
AU2021241257A1 (en) 2020-03-25 2022-10-13 Takeda Pharmaceutical Company Limited QD dosing of GIP receptor agonist peptide compounds and uses thereof
EP4126920A2 (en) 2020-03-25 2023-02-08 Takeda Pharmaceutical Company Limited Gif receptor agonist peptide compounds and uses thereof
CR20230530A (es) 2021-05-13 2024-02-19 Carmot Therapeutics Inc Moduladores de los receptores acoplados a proteínas g.
WO2023169456A1 (en) 2022-03-09 2023-09-14 Gasherbrum Bio , Inc. Heterocyclic glp-1 agonists
WO2023179542A1 (en) 2022-03-21 2023-09-28 Gasherbrum Bio , Inc. 5,8-dihydro-1,7-naphthyridine derivatives as glp-1 agonists for the treatment of diabetes
WO2023198140A1 (en) 2022-04-14 2023-10-19 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists

Family Cites Families (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US270488A (en) * 1883-01-09 Drilling apparatus
US2201270A (en) * 1936-04-17 1940-05-21 Mcintyre John Taylor Apparatus for allaying dust from rock drills
US2946565A (en) * 1953-06-16 1960-07-26 Jersey Prod Res Co Combination drilling and testing process
US2849214A (en) * 1954-09-02 1958-08-26 Gulf Research Development Co Borehole drilling apparatus for preventing lost circulation
US3497020A (en) * 1968-05-20 1970-02-24 Archer W Kammerer Jr System for reducing hydrostatic pressure on formations
JPS5011391B1 (pt) * 1970-07-21 1975-04-30
SE355840B (pt) * 1971-09-08 1973-05-07 Atlas Copco Ab
FR2228301B1 (pt) * 1973-05-03 1977-10-14 Ibm
US4147786A (en) * 1976-02-02 1979-04-03 Ciba-Geigy Corporation 1-Indolylalkyl-3-or 4-trimethyleneurido-piperidines
EP0000485A1 (de) 1977-07-08 1979-02-07 Ciba-Geigy Ag Piperidino-propanole, ihre Herstellung und pharmazeutische Präparate die diese enthalten
FI782133A (fi) * 1977-07-08 1979-01-09 Ciba Geigy Ag Piperidino-propanoler och foerfarande foer deras framstaellning
US4329348A (en) * 1979-02-26 1982-05-11 Ciba-Geigy Corporation N-Oxacyclic-alkylpiperidines as psychostimulants
US4630691A (en) * 1983-05-19 1986-12-23 Hooper David W Annulus bypass peripheral nozzle jet pump pressure differential drilling tool and method for well drilling
US4534426A (en) * 1983-08-24 1985-08-13 Unique Oil Tools, Inc. Packer weighted and pressure differential method and apparatus for Big Hole drilling
US4567954A (en) * 1983-12-02 1986-02-04 Norton Christensen, Inc. Replaceable nozzles for insertion into a drilling bit formed by powder metallurgical techniques and a method for manufacturing the same
US4695575A (en) * 1984-11-13 1987-09-22 Janssen Pharmaceutica, N.V. 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines
ZA928276B (en) 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
US5902272A (en) * 1992-01-07 1999-05-11 Arthrocare Corporation Planar ablation probe and method for electrosurgical cutting and ablation
US5595872A (en) * 1992-03-06 1997-01-21 Bristol-Myers Squibb Company Nucleic acids encoding microsomal trigyceride transfer protein
ZA931601B (en) 1992-03-06 1993-10-05 Squibb & Sons Inc Microsomal triglyceride transfer protein
US5355967A (en) * 1992-10-30 1994-10-18 Union Oil Company Of California Underbalance jet pump drilling method
GB9321557D0 (en) 1992-11-03 1993-12-08 Zeneca Ltd Carboxamide derivatives
GB9312806D0 (en) 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
GB9317104D0 (en) 1993-08-17 1993-09-29 Zeneca Ltd Therapeutic heterocycles
TW394760B (en) 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
IL112795A (en) * 1994-03-04 2001-01-28 Astrazeneca Ab Derivatives of peptides as antithrombotic drugs, their preparation, and pharmaceutical preparations containing them
US5456326A (en) * 1994-04-18 1995-10-10 Exxon Production Research Company Apparatus and method for installing open-ended tubular members axially into the earth
IL115420A0 (en) 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
CA2200468A1 (en) 1994-10-27 1996-05-09 Wayne J. Thompson Muscarine antagonists
PT798295E (pt) 1994-12-02 2003-07-31 Yamanouchi Pharma Co Ltd Novo derivado de amidinonaftilo ou sal deste
GB9508786D0 (en) * 1995-04-29 1995-06-21 Zeneca Ltd Substituted heterocycles
EP0828754B1 (en) 1995-05-29 2005-02-02 Pfizer Inc. Dipeptides which promote release of growth hormone
US5612353A (en) 1995-06-07 1997-03-18 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
US5849759A (en) 1995-12-08 1998-12-15 Berlex Laboratories, Inc. Naphthyl-substituted benzimidazole derivatives as anti-coagulants
GB9602294D0 (en) 1996-02-05 1996-04-03 Zeneca Ltd Heterocyclic compounds
ES2230624T5 (es) 1996-11-27 2010-10-25 Aventis Pharmaceuticals Inc. Composicion farmaceutica que comprende un compuesto que tiene actividad anti-xa y un compuesto antagonista de la agregacion plaquetaria.
AU7453498A (en) 1997-05-30 1998-12-30 Takeda Chemical Industries Ltd. Sulfonamide derivatives, their production and use
FR2764511B1 (fr) * 1997-06-13 2000-09-08 Sanofi Sa Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire
GB9715895D0 (en) 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic compounds
KR20010032175A (ko) 1997-11-20 2001-04-16 야스이 쇼사꾸 비페닐아미딘 유도체
BR9814987A (pt) 1997-11-21 2000-10-03 Schering Corp "oximas substituìdas como antagonistas da neurocinina"
EP1048652A4 (en) 1997-12-26 2001-05-09 Mochida Pharm Co Ltd AROMATIC COMPOUNDS WITH A CYCLIC AMINO GROUP OR THEIR SALTS
WO1999040075A1 (fr) * 1998-02-05 1999-08-12 Takeda Chemical Industries, Ltd. Derives de sulfamide, leur procede de production et leur utilisation
SK15072000A3 (sk) * 1998-04-10 2001-08-06 Japan Tobacco Inc. Amidové zlúčeniny
US6129152A (en) * 1998-04-29 2000-10-10 Alpine Oil Services Inc. Rotating bop and method
GB9809349D0 (en) 1998-05-02 1998-07-01 Zeneca Ltd Heterocyclic derivatives
US6423519B1 (en) * 1998-07-15 2002-07-23 Gpc Biotech Inc. Compositions and methods for inhibiting fungal growth
EP1104754A1 (en) 1998-08-11 2001-06-06 Daiichi Pharmaceutical Co., Ltd. Novel sulfonyl derivatives
JP2000080046A (ja) * 1998-09-03 2000-03-21 Dai Ichi Seiyaku Co Ltd 多臓器障害の予防・治療剤
WO2000018398A1 (en) 1998-09-25 2000-04-06 Sunol Molecular Corporation Pharmaceutically active compounds and methods of use thereof
PE20001353A1 (es) 1998-12-23 2000-12-07 Schering Corp Oximas e hidrazonas sustituidas como antagonistas de neuroquinina
US6204265B1 (en) * 1998-12-23 2001-03-20 Schering Corporation Substituted oximes and hydrazones as neurokinin antagonists
US7217714B1 (en) * 1998-12-23 2007-05-15 Agouron Pharmaceuticals, Inc. CCR5 modulators
CA2383492A1 (en) 1999-06-22 2000-12-28 Takeda Chemical Industries, Ltd. Acylhydrazine derivatives, their production and use
WO2001002397A1 (fr) 1999-06-30 2001-01-11 Mochida Pharmaceutical Co., Ltd. Composes tricycliques presentant une jonction spiro
KR20020087041A (ko) 1999-07-28 2002-11-21 아벤티스 파마슈티칼스 프로덕츠 인크. 치환된 옥소아자헤테로사이클릴 화합물
WO2001017992A1 (en) 1999-09-09 2001-03-15 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
EP1242366A1 (en) 1999-12-15 2002-09-25 Axys Pharmaceuticals, Inc. Salicylamides as serine protease and factor xa inhibitors
US6629974B2 (en) * 2000-02-22 2003-10-07 Gyrus Medical Limited Tissue treatment method
US6723091B2 (en) * 2000-02-22 2004-04-20 Gyrus Medical Limited Tissue resurfacing
AR033517A1 (es) 2000-04-08 2003-12-26 Astrazeneca Ab Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos
JP2002201178A (ja) * 2000-07-17 2002-07-16 Takeda Chem Ind Ltd スルホン誘導体、その製造法及び用途
CA2416384A1 (en) * 2000-07-17 2003-01-16 Takeda Chemical Industries, Ltd. Sulfone derivatives, their production and use
US6511973B2 (en) 2000-08-02 2003-01-28 Bristol-Myers Squibb Co. Lactam inhibitors of FXa and method
WO2002026720A2 (en) 2000-09-29 2002-04-04 Millennium Pharmaceuticals, Inc. PIPERAZINE BASED INHIBITORS OF FACTOR Xa
DK1331892T3 (da) * 2000-10-18 2006-10-30 Mattioli Eng Ltd Apparat til resurfacing af hud ved hjælp af plasma
FR2819511A1 (fr) 2001-01-18 2002-07-19 Servier Lab Nouveaux composes azepane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JPWO2002068407A1 (ja) 2001-02-28 2004-06-24 山之内製薬株式会社 ベンゾイミダゾール化合物
ES2298386T3 (es) 2001-07-26 2008-05-16 Eli Lilly And Company 1-glicinil-4-(1-metilpiperidin-4-il)piperazinas y -piperidinas como antagonistas del factor xa.
US6877571B2 (en) * 2001-09-04 2005-04-12 Sunstone Corporation Down hole drilling assembly with independent jet pump
AU2002336462A1 (en) 2001-09-06 2003-03-24 Millennium Pharmaceuticals, Inc. Piperazine and homopiperazine compounds
UA78232C2 (uk) 2001-09-21 2007-03-15 Брістол-Майерс Сквібб Компані Лактамвмісні сполуки та їх похідні як інгібітори фактора ха
JP4563675B2 (ja) * 2001-10-12 2010-10-13 ハイ・ポイント・ファーマスーティカルズ、エルエルシー 置換ピペリジン類、およびヒスタミンｈ３受容体関連疾患の治療のためのその使用
DE10155075A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Cyclische Sulfonamide
WO2003082847A1 (fr) 2002-03-28 2003-10-09 Tanabe Seiyaku Co., Ltd. Derive de benzofurane
TW200307667A (en) * 2002-05-06 2003-12-16 Bristol Myers Squibb Co Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
DE10229070A1 (de) 2002-06-28 2004-01-15 Merck Patent Gmbh Phenylderivate 5
US20040006490A1 (en) 2002-07-08 2004-01-08 Gingrich Mark A. Prescription data exchange system
WO2004031145A2 (en) * 2002-10-02 2004-04-15 Bristol-Myers Squibb Company Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors
AU2003271185A1 (en) 2002-10-15 2004-05-04 Takeda Pharmaceutical Company Limited Imidazopyridine derivative, process for producing the same, and use
CA2507026A1 (en) * 2002-11-22 2004-06-10 Takeda Pharmaceutical Company Limited Imidazole derivatives, their production and use
MXPA05008878A (es) * 2003-02-21 2005-10-05 Pfizer Derivados de aminotiazol sustituidos con cicloalquilo que contiene n y composiciones farmaceuticas para inhibir la proliferacion celular, y metodos para su uso.
US6899188B2 (en) * 2003-03-26 2005-05-31 Sunstone Corporation Down hole drilling assembly with concentric casing actuated jet pump
WO2005087266A1 (en) 2004-03-05 2005-09-22 Vddi Pharmaceuticals Combination therapy for inhibition of platelet aggregation
TWI396686B (zh) * 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
US7988933B2 (en) 2006-09-01 2011-08-02 Siemens Healthcare Diagnostics Inc. Identification system for a clinical sample container
KR100906250B1 (ko) 2006-09-04 2009-07-07 주식회사 엘지화학 바인더로서 고중합도 폴리비닐알콜과 폴리비닐피롤리돈의혼합물을 포함하는 전극 합제 및 이를 포함하는 리튬이차전지

Also Published As

Publication number Publication date
CN1989104B (zh) 2011-07-13
DK1748985T3 (da) 2011-08-29
TW200600508A (en) 2006-01-01
JP2008500385A (ja) 2008-01-10
EP1748985A1 (en) 2007-02-07
RU2006145449A (ru) 2008-06-27
PL1748985T3 (pl) 2011-11-30
HRP20110640T1 (hr) 2011-10-31
JP4129047B2 (ja) 2008-07-30
US8697865B2 (en) 2014-04-15
SI1748985T1 (sl) 2011-08-31
US20070244118A1 (en) 2007-10-18
US7745623B2 (en) 2010-06-29
CY1111850T1 (el) 2015-10-07
AU2005245298B2 (en) 2011-04-07
CN102093285A (zh) 2011-06-15
NO20065929L (no) 2007-02-19
CA2567506C (en) 2013-06-18
EP1748985B1 (en) 2011-06-22
CN1989104A (zh) 2007-06-27
HK1100666A1 (en) 2007-09-28
AU2005245298A1 (en) 2005-12-01
WO2005113504A1 (en) 2005-12-01
RS51925B (en) 2012-02-29
KR20070021205A (ko) 2007-02-22
US20080255352A1 (en) 2008-10-16
IL178896A0 (en) 2007-03-08
CA2567506A1 (en) 2005-12-01
US20100160629A1 (en) 2010-06-24
US20080255362A1 (en) 2008-10-16
EP2208726B1 (en) 2014-08-20
JP2008163030A (ja) 2008-07-17
TWI396686B (zh) 2013-05-21
CN102093285B (zh) 2013-10-16
KR101248637B1 (ko) 2013-03-28
ATE513813T1 (de) 2011-07-15
MY154461A (en) 2015-06-30
EP2208726A1 (en) 2010-07-21
RU2361861C2 (ru) 2009-07-20
PT1748985E (pt) 2011-07-29
JP4362535B2 (ja) 2009-11-11
MXPA06013243A (es) 2007-02-08
ES2368155T3 (es) 2011-11-14
IL178896A (en) 2012-07-31
NZ550985A (en) 2011-02-25

Similar Documents

Publication Publication Date Title
BRPI0511186A (pt) composto, pró-droga do composto, composição farmacêutica, uso do composto, e, processo para preparar o composto
NO20052976D0 (no) Fosfodiesterase-4-inhibitorer.
BRPI0510598A (pt) compostos de amida de aril ou heteroaril substituìdos
PE20040155A1 (es) Derivados aminoinazoles, procedimiento de preparacion e intermedios de este procedimiento a titulo de medicamentos y composiciones farmaceuticas que los contienen
CY1111706T1 (el) Παραγωγα αρυλο- και ετεροαρυλο-πιπεριδινοκαρβοξυλικων αλατων, η παρασκευη τους και η εφαρμογη τους ως αναστολεις του ενζυμου faah
TW200720252A (en) Cyclic amine derivative having substituted alkyl group
AR035815A1 (es) Derivados de piperidina, un proceso para su preparacion, composiciones y combinaciones farmacéuticas que comprenden a dichos derivados
EA200602067A1 (ru) Производные хиноксалин-2-она, содержащие их средства защиты полезных растений и способ их получения и их применение
CY1106969T1 (el) Αναστολεις dpp-iv
PE20030226A1 (es) Compuestos arilicos sustituidos con quinuclidinas para el tratamiento de enfermedades
EA200501477A1 (ru) Производные пиперидинил- и пиперазинилалкилкарбаматов, способы их получения и применение их в терапии
PE20080104A1 (es) Nitrilos espirociclicos como inhibidores de proteasa
BRPI0408338A (pt) piperidinas substituìdas como novos inibidores de mdm2-p53
ATE273295T1 (de) Verfahren zur herstellung von 6-substituierten (s)-nikotin-derivaten und zwischenverbindungen
DE60130766D1 (de) Serotoninwiederaufnahme-inhibitoren
PE20010485A1 (es) Derivados de bencimidazol sustituidos con aminocarbonilo, procedimiento para su preparacion y su utilizacion como medicamentos
DE60308187D1 (de) N-benzyl-3-phenyl-3-heterocyclyl-propionamid-verbindungen als tachykinin rezeptoren antagonisten und/oder als serotoninwiederaufnahme inhibitoren
AR040788A1 (es) 2,3- dihidro -isoindol-1-onas
BR0000184B1 (pt) processo para a preparação de compostos heterocìclicos.
AR038967A1 (es) Derivados de 2,3 - diaril - pirazolidinas como inhibidores de enzimas que degradan la neurotensina
DE60214414D1 (de) Peptidderivat, pharmazeutisch unbedenkliches salz davon, verfahren zu dessen herstellung und dessen verwendung
AR052931A1 (es) Derivados de piridina sustituidos como abridores de los canales kcnq, composiciones farmaceuticas que los contienen y su uso para el tratamiento de enfermedades del snc.
TH87272A (th) อนุพันธ์ไซคลิคเอไมด์และการผลิตกับการใช้ของสารนี้
TH83171A (th) วิธีการของการสังเคราะห์อนุพันธ์ 6-แอลคิลอะมิโนควิโนลีน
TH87272B (th) อนุพันธ์ไซคลิคเอไมด์และการผลิตกับการใช้ของสารนี้

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]